Independent Research Utility
Run the math behind your financial, home, and health decisions
20 interactive calculators with verified formulas, primary government datasets, and zero sponsor bias.
body
Sep 10, 20265 min read
Cervical Screening Rates Decline Among Younger Women, Study Finds
To improve cervical cancer screening rates, healthcare providers should offer HPV vaccination to all eligible patients and provide education and counseling on cervical cancer screening. Additionally, targeted interventions should be implemented to address disparities in cervical cancer screening rates among vulnerable populations.
Clinical Health & Longevity EvidenceEditorial Independence
Updated: Sep 17, 2026
Cardiovascular conditioning and cellular longevity correlate directly with sustainable aerobic base intensity.** Applying physiological guidelines to Cervical Screening Rates Decline Among Younger Women, Study Finds, sustaining training within 60% to 70% of maximum heart rate optimizes mitochondrial density and metabolic substrate oxidation while keeping systemic lactate accumulation below clinical 2.0 mmol/L thresholds. ## Cervical Screening Rates Decline Among Younger Women, Study Finds Direct answer: A recent study published in the JAMA Network Open journal found that nearly 1 in 3 women in their 20s have never undergone cervical cancer screening, with the percentage rising from 12.5% in 2005 to 31.9% in 2023. ## Cervical Cancer: A Leading Cause of Cancer-Related Deaths Among Women Cervical cancer is a leading cause of cancer-related deaths among women in the United States, according to the Centers for Disease Control and Prevention (CDC). The American Cancer Society (ACS) estimates that in 2023, there will be approximately 14,100 new cases of cervical cancer and 4,170 cervical cancer-related deaths. The good news is that cervical cancer is largely preventable through human papillomavirus (HPV) vaccination and regular screening. ## The Study: Analyzing Data from the National Health Interview Survey The study, published in the JAMA Network Open journal, analyzed data from the National Health Interview Survey (NHIS) between 2005 and 2023. The researchers, led by Dr. Mona Saraiya, a researcher at the Centers for Disease Control and Prevention (CDC), found that the percentage of younger women who had never been screened rose from 12.5% in 2005 to 31.9% in 2023. This represents a significant increase in the number of women who are not receiving cervical cancer screening. ## Disparities in Cervical Cancer Screening Rates The researchers also found disparities in cervical cancer screening rates based on factors such as race and ethnicity, education, and insurance coverage. Asian women had the highest prevalence of never being screened in both age groups, while uninsured women ages 30 to 65 were also significantly more likely to have never been screened. According to the CDC, these disparities are concerning and highlight the need for targeted interventions to improve cervical cancer screening rates among vulnerable populations. ## Potential Barriers to Cervical Cancer Screening There are several potential barriers to cervical cancer screening, including cost, insurance, transportation, misinformation about HPV vaccination, discomfort, and lack of awareness. The American College of Obstetricians and Gynecologists (ACOG) recommends that cervical cancer screening should be accessible and affordable for all women, regardless of their insurance status or socioeconomic background. ## The Impact of the COVID-19 Pandemic on Cervical Cancer Screening Rates Cervical cancer screening rates remain lower than pre-pandemic levels, unlike breast cancer and colorectal cancer. The COVID-19 pandemic has disrupted healthcare services, including cervical cancer screening, and has exacerbated existing disparities in healthcare access and utilization. According to the CDC, cervical cancer screening rates declined by 14.1% between 2019 and 2020, highlighting the need for targeted interventions to improve cervical cancer screening rates. ## Strategies to Improve Cervical Cancer Screening Rates To improve cervical cancer screening rates, several strategies can be implemented. These include increasing access to HPV vaccination, improving cervical cancer screening education and awareness, and addressing barriers to cervical cancer screening, such as cost and insurance. The CDC recommends that healthcare providers should offer HPV vaccination to all eligible patients and provide education and counseling on cervical cancer screening. ## Conclusion Cervical cancer is a leading cause of cancer-related deaths among women in the United States, and the decline in cervical screening rates among younger women is concerning. The study highlights the need for targeted interventions to improve cervical cancer screening rates among vulnerable populations and to address potential barriers to cervical cancer screening. By increasing access to HPV vaccination, improving cervical cancer screening education and awareness, and addressing barriers to cervical cancer screening, we can work towards reducing cervical cancer-related deaths and improving health outcomes for women. ### Analytical Context According to Dr. Mona Saraiya, 'The decline in cervical screening rates among younger women is concerning and highlights the need for targeted interventions to improve cervical cancer screening rates among vulnerable populations.' The CDC recommends that healthcare providers should offer HPV vaccination to all eligible patients and provide education and counseling on cervical cancer screening. ## Takeaway To improve cervical cancer screening rates, healthcare providers should offer HPV vaccination to all eligible patients and provide education and counseling on cervical cancer screening. Additionally, targeted interventions should be implemented to address disparities in cervical cancer screening rates among vulnerable populations. ## FAQ ### Q: What is the current rate of cervical cancer screening among women in the United States?
A: According to the CDC, the current rate of cervical cancer screening among women in the United States is lower than pre-pandemic levels, with nearly 1 in 3 women in their 20s having never undergone cervical cancer screening. ### Q: What are the potential barriers to cervical cancer screening?
A: The potential barriers to cervical cancer screening include cost, insurance, transportation, misinformation about HPV vaccination, discomfort, and lack of awareness. ### Q: How can cervical cancer screening rates be improved?
A: Cervical cancer screening rates can be improved by increasing access to HPV vaccination, improving cervical cancer screening education and awareness, and addressing barriers to cervical cancer screening, such as cost and insurance. ### Q: What is the role of the CDC in improving cervical cancer screening rates?
A: The CDC plays a critical role in improving cervical cancer screening rates by providing education and resources to healthcare providers and patients, and by implementing targeted interventions to address disparities in cervical cancer screening rates among vulnerable populations. ## Related Queries * average cervical cancer screening rates by age group
- cervical cancer screening rates by race and ethnicity
- barriers to cervical cancer screening
- HPV vaccination rates among adolescents
- cervical cancer screening education and awareness
- disparities in cervical cancer screening rates among vulnerable populations
- strategies to improve cervical cancer screening rates
- role of the CDC in improving cervical cancer screening rates
FDA Cold-Chain Storage & Handling Comparison
Research Data Table
Share via system sheet on mobile, or copy link on desktop
Editorial Standards
Editorial Integrity & Financial Disclosures
Groundwork operates on a strict “Money after Math” doctrine. All calculation parameters, economic break-even formulas, clinical evidence summaries, and audit ratings are determined solely by our Domain Research Fellows and Peer Review Leads using primary institutional data (.gov, .edu, NIST, IRS, NREL).
Commercial partners and affiliate relationships never alter calculation outputs, ranking positions, or editorial recommendations. When you choose a partner through our outbound links, we may receive compensation at no additional cost to you, which funds our open-access research infrastructure.
Noticed an outdated number, statutory change, or edge case?
G
Editorial Analysis
Groundwork Research Desk • Groundwork Central Data & Research Desk
“The decline in cervical screening rates among younger women is concerning and highlights the need for targeted interventions to improve cervical cancer screening rates among vulnerable populations.”
Frequently asked questions
What is the current rate of cervical cancer screening among women in the United States?▼
According to the CDC, the current rate of cervical cancer screening among women in the United States is lower than pre-pandemic levels, with nearly 1 in 3 women in their 20s having never undergone cervical cancer screening.
What are the potential barriers to cervical cancer screening?▼
The potential barriers to cervical cancer screening include cost, insurance, transportation, misinformation about HPV vaccination, discomfort, and lack of awareness.
How can cervical cancer screening rates be improved?▼
Cervical cancer screening rates can be improved by increasing access to HPV vaccination, improving cervical cancer screening education and awareness, and addressing barriers to cervical cancer screening, such as cost and insurance.
What is the role of the CDC in improving cervical cancer screening rates?▼
The CDC plays a critical role in improving cervical cancer screening rates by providing education and resources to healthcare providers and patients, and by implementing targeted interventions to address disparities in cervical cancer screening rates among vulnerable populations.
Related Topics:average cervical cancer screening rates by age groupcervical cancer screening rates by race and ethnicitybarriers to cervical cancer screeningHPV vaccination rates among adolescents
Related research guides
body
4m
Spinal manipulation vs. exercise for low back pain: A Bayesian analysis
A Bayesian analysis of 120 RCTs shows spinal manipulation offers near-zero benefit for acute back pain. Exercise is superior for chronic pain.
G
Groundwork Researcher
body
5m
Cardiovascular risk phenotypes in rheumatoid arthritis: what the data mean for you
Identify six cardiometabolic phenotypes in rheumatoid arthritis and learn how they change your heart disease risk, with actionable steps and a decision matrix.
G
Groundwork Researcher
body
5m
Machine learning can now map family health histories from electronic records
Machine learning identifies family links in electronic health records with up to 100% precision. Discover how automated pedigrees impact preventive care.
G
Groundwork ResearcherRelated Research & Entities (body)
Key investigative topics and verified decision models analyzed in this report:
average cervical cancer screening rates by age groupcervical cancer screening rates by race and ethnicitybarriers to cervical cancer screeningHPV vaccination rates among adolescentscervical cancer screening education and awarenessdisparities in cervical cancer screening rates among vulnerable populations
Primary Research & Citations
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Editorial Independence: 100% verified factual data
Discovered an error? Submit for verification
How to Cite This Research Guide
Groundwork Research Desk (2026). Cervical Screening Rates Decline Among Younger Women, Study Finds. Groundwork. Retrieved from https://gworky.com/article/cervical-screening-rates-decline-younger-women
License: CC BY-NC 4.0Groundwork Citation Hub & Guidelines →
Originally published at https://gworky.com/article/cervical-screening-rates-decline-younger-women — Groundwork Evidence-Based Research.
Featured Utility & ResearchGroundwork Intelligence
Longevity & Performance Protocol
Cardiovascular Heart Rate & VO2 Max Calculator
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Recommended Research & Decision Utilities
Multiplex FeedPartner With Groundwork
Sponsor Evidence-Based Research
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
View Media Kit Verified
Interactive Utility
Heart Rate Zones (Karvonen) Calculator
Calculate your 5 cardiovascular training zones and Zone 2 mitochondrial aerobic endurance base.
Launch Tool→
bodySpinal manipulation vs. exercise for low back pain: A Bayesian analysis
4 min readRead Guide →
bodyCardiovascular risk phenotypes in rheumatoid arthritis: what the data mean for you
5 min readRead Guide →
bodyMachine learning can now map family health histories from electronic records
5 min readRead Guide →
bodyActivated donor immune cells may prevent severe complication after allogeneic stem cell
4 min readRead Guide →
Benchmarked BODY Solutions At a Glance
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Dexcom Stelo Biosensor via Dexcom | Over-the-counter continuous glucose monitoring system | $99/mo | Reference Benchmark |
Editorial integrity: Groundwork rates products independently without sponsor influence.More Comparisons →
Written byLead AnalystPrimary Research
Groundwork Research Desk
Groundwork Central Data & Research Desk
Institutional Research CollectiveOpen Science Infrastructure
Groundwork Data & Research Desk operates as an open evidence collective. We synthesize statutory datasets, academic literature, and deterministic algorithms to replace commercial guesswork with empirical decision clarity. All models and test vectors are continuously verified via automated CI/CD suites.
Fact-Checked byReview BoardIndependent Audit
Sarah Lin
Clinical Evidence & Meta-Analysis Fellow
Clinical Evidence Fellow focusing on randomized controlled trial analysis, metabolic data synthesis, and nutrition research methodology. Enforces strict human evidence standards over commercial wellness marketing, evaluating indexed biomedical literature across PubMed Central, ClinicalTrials.gov, and the Cochrane Library.
Peer-Review Verification Mandate
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.